|
Atomistry » Magnesium » PDB 4qhe-4qpz » 4qpf | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Magnesium » PDB 4qhe-4qpz » 4qpf » |
Magnesium in PDB 4qpf: New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone ResorptionEnzymatic activity of New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption
All present enzymatic activity of New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption:
2.5.1.1; 2.5.1.10; Protein crystallography data
The structure of New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption, PDB code: 4qpf
was solved by
F.H.Ebetino,
M.Lundy,
A.A.Kwaasi,
J.E.Dunford,
Z.Duan,
J.Triffitt,
A.Mazur,
G.Jeans,
B.L.Barnett,
R.G.G.Russell,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 4qpf:
The structure of New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption
(pdb code 4qpf). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 3 binding sites of Magnesium where determined in the New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption, PDB code: 4qpf: Jump to Magnesium binding site number: 1; 2; 3; Magnesium binding site 1 out of 3 in 4qpfGo back to![]() ![]()
Magnesium binding site 1 out
of 3 in the New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption
![]() Mono view ![]() Stereo pair view
Magnesium binding site 2 out of 3 in 4qpfGo back to![]() ![]()
Magnesium binding site 2 out
of 3 in the New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption
![]() Mono view ![]() Stereo pair view
Magnesium binding site 3 out of 3 in 4qpfGo back to![]() ![]()
Magnesium binding site 3 out
of 3 in the New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption
![]() Mono view ![]() Stereo pair view
Reference:
F.H.Ebetino,
M.Lundy,
A.A.Kwaasi,
J.E.Dunford,
Z.Duan,
J.Triffitt,
A.Mazur,
G.Jeans,
B.L.Barnett,
R.G.G.Russell.
New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption To Be Published.
Page generated: Tue Aug 20 02:07:53 2024
|
Last articlesZn in 9MJ5Zn in 9HNW Zn in 9G0L Zn in 9FNE Zn in 9DZN Zn in 9E0I Zn in 9D32 Zn in 9DAK Zn in 8ZXC Zn in 8ZUF |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |